Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled study

Basit Öğe Kaydı
dc.authorid0000-0002-3448-0490en_US
dc.authorscopusid57189367146en_US
dc.authorwosidABI-3906-2020en_US
dc.contributor.authorÖzturk, Savaş
dc.contributor.authorTurgutalp, Kenan
dc.contributor.authorArıcı, Mustafa
dc.contributor.authorGök, Mahmut
dc.contributor.authorİslam, Mahmud
dc.contributor.authorAltıparmak, Mehmet Rıza
dc.contributor.authorAydın, Zeki
dc.contributor.authorDöner, Barıs
dc.contributor.authorEren, Necmi
dc.contributor.authorŞengül, Erkan
dc.contributor.authorKaradağ, Serhat
dc.contributor.authorÖzler, Tuba Elif
dc.contributor.authorDheir, Hamad
dc.contributor.authorPembegül, İrem
dc.contributor.authorTaymez, Dilek Güven
dc.contributor.authorŞahin, Garip
dc.contributor.authorDolarslan, Murside Esra
dc.contributor.authorSoypaçacı, Zeki
dc.contributor.authorHür, Ender
dc.contributor.authorKara, Ekrem
dc.contributor.authorBaştürk, Taner
dc.contributor.authorÖğütmen, Melike Betül
dc.contributor.authorGörgülü, Numan
dc.contributor.authorŞahin, İdris
dc.contributor.authorAyli, Mehmet Deniz
dc.contributor.authorTuğlular, Zübeyde Serhan
dc.contributor.authorŞahin, Gülizar
dc.contributor.authorTokgöz, Bülent
dc.contributor.authorTonbul, Halil Zeki
dc.contributor.authorYıldız, Alaattin
dc.contributor.authorSezer, Siren
dc.contributor.authorOdabaş, Ali Rıza
dc.contributor.authorAteş, Kenan
dc.contributor.authorBakırdöğen, Serkan
dc.date.accessioned2023-04-17T11:08:58Z
dc.date.available2023-04-17T11:08:58Z
dc.date.issued2021en_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractObjective Older adults with co-morbidities have been reported to be at higher risk for adverse outcomes of coronavirus disease 2019 (COVID-19). The characteristics of COVID-19 in older patients and its clinical outcomes in different kidney disease groups are not well known. Methods Data were retrieved from a national multicentric database supported by Turkish Society of Nephrology, which consists of retrospectively collected data between 17 April 2020 and 31 December 2020. Hospitalised patients aged 18 years or older with confirmed COVID-19 diagnosis suffering from stage 3-5 chronic kidney disease (CKD) or on maintenance haemodialysis (HD) treatment were included in the database. Non-uraemic hospitalised patients with COVID-19 were also included as the control group. Results We included 879 patients [388 (44.1%) female, median age: 63 (IQR: 50-73) years]. The percentage of older patients in the CKD group was 68.8% (n = 188/273), in the HD group was 49.0% (n = 150/306) and in the control group was 30.4% (n = 70/300). Co-morbidities were higher in the CKD and HD groups. The rate of presentation with severe-critical disease was higher in the older CKD and HD groups (43.6%, 55.3% and 16.1%, respectively). Among older patients, the intensive care unit (ICU) admission rate was significantly higher in the CKD and HD groups than in the control group (38.8%, 37.3% and 15.7%, respectively). In-hospital mortality or death and/or ICU admission rates in the older group were significantly higher in the CKD (29.3% and 39.4%) and HD groups (26.7% and 30.1%) compared with the control group (8.6% and 17.1%). In the multivariate analysis, in-hospital mortality rates in CKD and HD groups were higher than control group [hazard ratio (HR): 4.33 (95% confidence interval [CI]: 1.53-12.26) and HR: 3.09 (95% CI: 1.04-9.17), respectively]. Conclusion Among older COVID-19 patients, in-hospital mortality is significantly higher in those with stage 3-5 CKD and on maintenance HD than older patients without CKD regardless of demographic characteristics, co-morbidities, clinical and laboratory data on admission.en_US
dc.identifier.citationÖzturk, S., Turgutalp, K., Arıcı, M., Gök, M., Islam, M., Altıparmak, M. R., … Hür, E. (2021). Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID‐19: A multicenter nationwide controlled study. International Journal of Clinical Practice, 75(9). https://doi.org/10.1111/ijcp.14428en_US
dc.identifier.doi10.1111/ijcp.14428
dc.identifier.issn1368-5031
dc.identifier.issn1742-1241
dc.identifier.issue9en_US
dc.identifier.pmid34085352
dc.identifier.scopus2-s2.0-85108331460
dc.identifier.urihttps://doi.org/10.1111/ijcp.14428
dc.identifier.urihttps://hdl.handle.net/20.500.12428/4007
dc.identifier.volume75en_US
dc.identifier.wosWOS:000662739800001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorBakırdöğen, Serkan
dc.language.isoen
dc.publisherJohn Wiley & Sons Ltden_US
dc.relation.ispartofInternational Journal of Clinical Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRenal-Diseaseen_US
dc.subjectMortalityen_US
dc.subjectRisken_US
dc.subjectHemodialysisen_US
dc.subjectPopulationen_US
dc.subjectDeathen_US
dc.subjectInfectionen_US
dc.titleCharacteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled study
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Serkan_Bakirdogen_Makale.pdf
Boyut:
1.37 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Araştırma Makalesi
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu